Last reviewed · How we verify
NCT03670225
Evaluating Clinical Acceptance of a NPWT Wound Care System
NA trial testing Invia Motion Endure in Diabetic Foot Ulcer in 10 participants. Completed in 30 January 2020.
30 January 2020
Quick facts
| Lead sponsor | Medela AG |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 10 |
| Start date | 16 October 2018 |
| Primary completion | 30 January 2020 |
| Estimated completion | 30 January 2020 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Invia Motion Endure
Conditions studied
- Diabetic Foot Ulcer — all drugs for Diabetic Foot Ulcer →
- Pressure Injury — all drugs for Pressure Injury →
- Pressure Ulcer — all drugs for Pressure Ulcer →
Sponsor
Medela AG
Who can join
18 and older, any sex, with Diabetic Foot Ulcer or Pressure Injury. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Determine if use of the Medela Invia Motion NPWT system supports acceptable progress towards the goal of therapy when treating patients with a variety of wound types during the evaluation period.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03670225
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Diabetic Foot Ulcer
Currently open trials in the same condition.
- NCT07161830 — Evaluating the Efficacy of OCM™ (Omeza® Complete Matrix) in the Treatment of Diabetic Foot Ulcers · NA · recruiting
- NCT07396376 — Evaluation of ELU42 Topical Spray for the Treatment of Diabetic Foot Ulcers · Phase 1, PHASE2 · recruiting
- NCT07291817 — Intermittent Negative Pressure for Patients With Diabetic Foot Ulcers (INPRESS) Study · NA · recruiting
- NCT07209358 — EDX110 Randomized Control Trial for Treatment of DFUs · NA · recruiting
- NCT06938685 — Evaluating the Efficacy NeoThelium FT in the Treatment of Diabetic Foot Ulcers · NA · recruiting
Other Medela AG trials
Trials by the same sponsor.
- NCT04619212 — Initiate Study Evaluating if Mothers Who Are Both Breastfeeding and Pumping in the First Days After Delivery Report Impr · NA · completed
- NCT04593693 — A Dual-center Study Evaluating Clinical Acceptance of a NPWT Wound Care System · NA · completed
- NCT03921918 — Evaluation of Fluid-Filled Expression Core Technology Study - I · NA · completed
- NCT03091985 — Influence of the Brownie Breast Shield on the Dynamics of Milk Removal · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03670225 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Medela AG
- Last refreshed: 20 March 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03670225.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing